If the effect seems weaker late in a pen, is that treatment failure
Epigallocatechin gallate (50 mg/kg/day) also exerts multiple beneficial effects via the FGF21-AMPK pathway, including downregulation of lipogenic genes (e.g., SREBP-1c, 40%55%), reduction of hepatic lipid droplet accumulation, and enhancement of antioxidant capacity (Bakun et al., 2023
But if you look at the case reports, the case series, I dont think its going to be dramatic, and I dont think its going to be enough for the majority of psoriasis patients
Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers
These modifications dramatically reduce its binding to insulin-like growth factor-binding proteins (IGFBPs)